Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 243 Neoplasms 15 Neoplasm Metastasis 12 Carcinoma, Intraductal, Noninfiltrating 11 Breast Diseases 8 Advanced Breast Cancer 8 Breast Neoplasms, Male 7 Breast Carcinoma In Situ 7 Triple Negative Breast Neoplasms 5 Arthralgia 4 Ovarian Neoplasms 3 Neoplasms by Site 3 Breast Cancer Metastatic 3 Uterine Cervical Neoplasms 2 Recurrence 2 Patient Compliance 2 Osteoporosis 2 Obesity 2 Endometrial Neoplasms 2 Breast Neoplasm Female 2 Vitamin D Deficiency 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunctions, Psychological 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pain 1 Nutrition Disorders 1

Interventions

ribociclib 1 Tretinoin 1 Letrozole 1 Goserelin 1 Drug Therapy 1 Chemotherapy, Adjuvant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

HER2 Negative Breast Cancer × Anastrozole × Breast × Clear all

NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡